Akebia Therapeutics, Inc 10-K for FY2022
Akebia Therapeutics, Inc. (AKBA)
10-K
2023-03-10
For: 2022-12-31
View Original
Added on
April 11, 2026
About this 10-K
Akebia Therapeutics, Inc filed this 10-K on March 10, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $292.6M
- up 37.0% from $213.58M a year earlier
- Net loss
- $92.56M
- compared with a net loss of $282.84M a year earlier
- Diluted EPS
- -$0.51
- compared with -$1.70 a year earlier